Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D.

Surman SL, Penkert RR, Jones BG, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2016 Jan 6;23(3):219-27. doi: 10.1128/CVI.00739-15.

2.

Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8+ T Cells Among Airway Lymphocytes After Influenza Vaccination of Mice Deficient in Vitamins A + D.

Surman SL, Jones BG, Woodland DL, Hurwitz JL.

Viral Immunol. 2017 Dec;30(10):737-743. doi: 10.1089/vim.2017.0086. Epub 2017 Nov 13.

3.

Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.

Surman SL, Jones BG, Sealy RE, Rudraraju R, Hurwitz JL.

Vaccine. 2014 May 7;32(22):2521-4. doi: 10.1016/j.vaccine.2014.03.025. Epub 2014 Mar 21.

4.

Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.

Surman SL, Jones BG, Rudraraju R, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2014 Apr;21(4):598-601. doi: 10.1128/CVI.00757-13. Epub 2014 Feb 19.

5.

Vitamin A deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract.

Surman SL, Rudraraju R, Sealy R, Jones B, Hurwitz JL.

Viral Immunol. 2012 Aug;25(4):341-4. doi: 10.1089/vim.2012.0023. Epub 2012 Jul 19.

6.

Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice.

Rudraraju R, Surman SL, Jones BG, Sealy R, Woodland DL, Hurwitz JL.

Clin Vaccine Immunol. 2012 May;19(5):757-65. doi: 10.1128/CVI.05576-11. Epub 2012 Mar 7.

7.

Prenatal vitamin A deficiency impairs adaptive immune responses to pentavalent rotavirus vaccine (RotaTeq®) in a neonatal gnotobiotic pig model.

Kandasamy S, Chattha KS, Vlasova AN, Saif LJ.

Vaccine. 2014 Feb 7;32(7):816-24. doi: 10.1016/j.vaccine.2013.12.039. Epub 2013 Dec 29.

PMID:
24380684
8.

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.

10.

Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.

Wang D, Christopher ME, Nagata LP, Zabielski MA, Li H, Wong JP, Samuel J.

J Clin Virol. 2004 Dec;31 Suppl 1:S99-106.

PMID:
15567101
11.

Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells.

Penkert RR, Surman SL, Jones BG, Sealy RE, Vogel P, Neale G, Hurwitz JL.

Int Immunol. 2016 Mar;28(3):139-52. doi: 10.1093/intimm/dxv064. Epub 2015 Oct 27.

12.

Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.

de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.

Vaccine. 2012 Jul 6;30(32):4884-91. doi: 10.1016/j.vaccine.2012.04.032. Epub 2012 Apr 23.

PMID:
22537989
13.

Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.

Rudraraju R, Jones BG, Surman SL, Sealy RE, Thomas PG, Hurwitz JL.

PLoS One. 2014 Jan 22;9(1):e86554. doi: 10.1371/journal.pone.0086554. eCollection 2014.

15.

Programming the magnitude and persistence of antibody responses with innate immunity.

Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, Nakaya HI, Ravindran R, Stewart S, Alam M, Kwissa M, Villinger F, Murthy N, Steel J, Jacob J, Hogan RJ, García-Sastre A, Compans R, Pulendran B.

Nature. 2011 Feb 24;470(7335):543-7. doi: 10.1038/nature09737.

16.

Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.

Liu H, Patil HP, de Vries-Idema J, Wilschut J, Huckriede A.

PLoS One. 2013 Jul 31;8(7):e69649. doi: 10.1371/journal.pone.0069649. Print 2013.

17.

Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.

Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, Yoshikawa T, Kubota-Koketsu R, Ikuta K, Okamoto S, Mori Y, Kunisawa J, Kiyono H, Itoh N, Nagano K, Kamada H, Tsutsumi Y, Tsunoda S.

J Virol. 2010 Dec;84(24):12703-12. doi: 10.1128/JVI.01182-10. Epub 2010 Sep 29.

18.

Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.

Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, Rhee JH, Lee SE.

Vaccine. 2012 Jan 5;30(2):466-74. doi: 10.1016/j.vaccine.2011.10.058. Epub 2011 Oct 31.

PMID:
22051136
19.

Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.

Bian C, Liu S, Liu N, Zhang G, Xing L, Song Y, Duan Y, Gu H, Zhou Y, Zhang P, Li Z, Zhang K, Wang Z, Zhang S, Wang X, Yang P.

Antiviral Res. 2014 Apr;104:110-7. doi: 10.1016/j.antiviral.2014.01.022. Epub 2014 Feb 6.

PMID:
24509239
20.

[Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].

Sergeeva MV, Kuznetsov VV, Kas'ianenko MA, Shaldzhian AA, Repko IA, Potapchuk MV, Romanova IuR, Tsybalova LM.

Vopr Virusol. 2013 Nov-Dec;58(6):36-9. Russian.

PMID:
24772645

Supplemental Content

Support Center